ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ºúÃÎÑÕ£©ÄÔµí·ÛÑùѪ¹Ü²¡£¡£¨Cerebral amyloid angiopathy£¬CAA£©ÊǦµí·ÛÑùÂѰ×ÔÚÈíÄÔĤ¼°Æ¤ÖʵÄѪ¹Ü±ÚÉϳÁ»ýµ¼ÖÂBBBÆÆËðµÄÒ»ÖÖÄÔСѪ¹Ü²¡¡£¡£¾ÞÊÉϸ°ûÆ×ϵϸ°û×÷Ϊ´óÄÔÖÐɨ³ýA¦Â×îÖ÷ÒªµÄϸ°û£¬ÔÚ½µµÍA¦ÂµÄͬʱҲ»á±¬·¢µ¹ÔËÓÚ¼²²¡ÐÞ¸´µÄÒò×Ó¡£¡£Ç¨áãСÌåÊÇÒ»ÖÖнü·¢Ã÷¾ß±¸Ôö½ø¾ÞÊÉϸ°ûÎïÖʽ»Á÷ÄÜÁ¦µÄ°ûÍâÄÒÅÝ£¬µ«ÆäÓëCAAµÄ²¡ÀíÐÄÀíµÄ¹ØÏµÈÔÓдý¾ò¿Í¡£¡£
7ÔÂ4ÈÕ£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÔ²¡ÖÐÐIJÌε¸±Ñо¿Ô±¡¢¡¢¡¢Â½ÕýÆë½ÌÊÚ£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÁõÇ¿½ÌÊÚÔÚ¡¶×ÔȻͨѶ¡·£¨Nature Communications£©ÔÓÖ¾½ÒÏþÌâΪ"Macrophage lineage cells-derived migrasomes activate complement-dependent blood-brain barrier damage in cerebral amyloid angiopathy mouse model"µÄÑо¿ÂÛÎÄ¡£¡£
Ñо¿Ê״η¢Ã÷ÔÚÄÔµí·ÛÑùѪ¹Ü²¡£¡£¨Cerebral amyloid angiopathy, CAA£©ÖУ¬¾ÞÊÉϸ°ûÍÌÊÉѪ¹Ü±ÚÖеĵí·ÛÑùÂѰ×1-40£¨Beta amyloid peptide 1-40, A¦Â40£©ºó±¬·¢Ç¨áãСÌ壬´Ó¶øÆÆËðѪÄÔÆÁÕÏ(Blood brain barrier, BBB)ÍêÕûÐÔ£¬¼Ó¾çCAAµÄ²¡ÇéÏ£Íû¡£¡£ÉîÈë̽Ë÷·¢Ã÷£¬A¦Â40ÓÕµ¼¾ÞÊÉϸ°û±¬·¢µÄǨáãСÌåͨ¹ýCD5LÔö½øÑª¹ÜÄÚÆ¤Ï¸°ûµÄ²¹ÌåÒÀÀµµÄϸ°û¶¾Ð§Ó¦½ø¶øÆÆËðBBB¡£¡£Ñо¿ÍŶÓÓÉ´ËÌá³ö£¬Ç¨áãСÌåÊÇÒ»¸ö¾ß±¸Ç±ÔÚÑо¿¼ÛÖµµÄ·Ö×Ӱб꣬ÆäÔÚCAA²¡ÔîÄÔ×éÖ¯ÖоßÓÐѪ¹Ü𤸽»îÐÔ¡¢¡¢¡¢Ôö½ø²¹Ì弤»î¼°BBBËðÉ˵Ä×÷Ó㻣»£»Ê×´ÎÆÊÎöÁËCAAµÄÏà¹Ø·¢²¡»úÖÆ£¬ÎªÎ´À´CAAµÄÁÙ´²ÖÎÁÆÌṩÁ˾«×¼µÄ¸ÉÔ¤°Ðµã¡£¡£
¸ÃÑо¿Í¨¹ý¶Ô»¼ÕßѪ½¬¾ÙÐÐ΢Á£×ÓÁ÷ʽÆÊÎö·¢Ã÷£¬Ó뿵½¡ÊÜÊÔÕßÏà±È£¬CAA»¼ÕßÍâÖÜѪÖÐǨáãСÌ屬·¢Ôö¶à£¬ÇÒÔöÁ¿Ö÷ҪȪԴÓÚµ¥ºËϸ°û¡£¡£½øÒ»²½ÆÊÎö·¢Ã÷£¬CAA»¼ÕßÍâÖÜѪÖоÞÊÉϸ°û±¬·¢Ç¨áãСÌåµÄÄÜÁ¦Óë¼²²¡Ó°Ïñѧָ±êÇ×½üÏà¹Ø¡£¡£ÍŶÓÔÚÑо¿ÖÐʹÓÃTg-SwDI/BСÊó¼°5xFADСÊó×÷ΪCAA¶¯ÎïÄ£×Ó£¬ÒÔÒ°ÉúÐÍC57/Bl6Å侰СÊó×÷Ϊ±ÈÕÕ£¬·¢Ã÷¶¯ÎïÄ£×ÓµÄÄÔѪ¹ÜÖб£´æÇ¨áãСÌåµÄ³Á»ý£¬ÇÒȪԴÓÚ¾ÞÊÉϸ°ûÆ×ϵϸ°û£¨°üÀ¨Ñª¹ÜÅÔ¾ÞÊÉϸ°û¡¢¡¢¡¢Ð¡½ºÖÊϸ°ûÒÔ¼°ÍâÖܵ¥ºËϸ°ûȪԴµÄ¾ÞÊÉϸ°û£©¡£¡£½øÒ»²½É¸Ñ¡CAAÖÐÓÕµ¼Ç¨áãСÌ屬·¢µÄÖ÷ÒªÒòËØ£¬·¢Ã÷A¦Â40Êǵ¥ºË¾ÞÊÉϸ°ûǨáãСÌåÐγɵÄÖ÷ÒªÓÕµ¼Òò×Ó¡£¡£ÔÚÑо¿A¦Â40ÓÕµ¼µÄǨáãСÌåÔÚCAAÖеÄÐÄÀí²¡ÀíÀú³ÌÖУ¬ÍŶӷ¢Ã÷ÆäÔÚÌåÄÚÌåÍâ¾ùÄÜÆÆËðBBB¡£¡£½øÒ»²½¾ÙÐÐÂѰ×ÖÊ×éѧÆÊÎö·¢Ã÷Æä¿Éͨ¹ýCD5L¼¤»î²¹ÏµÒ»Çнø¶øÆÆËðѪÄÔÆÁÕÏ¡£¡£¶ÔCAAСÊó¾ÙÐп¹²¹ÌåÖÎÁÆ£¨PMX-53£©¿Éͨ¹ýÓÐÓÃÄæ×ªÑªÄÔÆÁÕÏµÄÆÆËð¼°ËèÇÊɥʧ´Ó¶øÊ©Õ¹±£»£»£»¤×÷Óᣡ£
×ÛÉÏËùÊö£¬¸ÃÑо¿±¨¸æÁËA¦Â40¿ÉÒÔÓÕµ¼¾ÞÊÉϸ°û±¬·¢¾ßÓÐѪ¹Ü𤸽ÐÔÇÒ¸»º¬CD5LµÄǨáãСÌ壬Æä´ó×ÚÕ³¸½ÓÚѪ¹Ü±ÚÖ¾ֲ¿CD5LŨ¶ÈÔö¸ß£¬½øÒ»²½Ï÷Èõ»úÌ忹²¹Ì弤»îµÄ±£»£»£»¤»úÖÆ£¬×îÖÕµ¼Ö²¹Ìå½éµ¼µÄϸ°û¶¾Ð§Ó¦£¬ÓÕ·¢BBBËðÉË¡£¡£ÔÚCAA»¼ÕßÁÙ´²Ñо¿ºÍÏà¹Ø¶¯ÎïÄ£×ÓÖУ¬¾ÞÊÉϸ°ûȪԴµÄǨáãСÌåÓëĤ¹¥»÷¸´ºÏÎMembrane attack complex£¬MAC£©Ë®Æ½ºÍCAA¼²²¡µÄÑÏÖØ³Ì¶È¾ßÓÐÇ×½üÏà¹ØÐÔ£¬Òò¶øÉÏÊöÁ½ÏîÖ¸±ê¿ÉÄܾßÓÐÐÖúCAAÕï¶ÏµÄÑо¿¼ÛÖµ¡£¡£ÁíÒ»·½Ã棬¿¹²¹ÌåÖÎÁÆ¿ÉÓÐÓüõÇáǨáãСÌå½éµ¼µÄBBBËðÉË¡£¡£Òò´Ë£¬¾ÞÊÉϸ°ûȪԴµÄǨáãСÌå¼°Æä½éµ¼µÄ²¹Ì弤»î;¾¶¿ÉÄÜÊÇCAAµÄDZÔÚÉúÎï±ê¼ÇÎïºÍÖÎÁưеã̽ÌÖµÄÖ÷ҪƫÏò¡£¡£

ͼ1£º£º£ºA¦ÂÓÕµ¼¾ÞÊÉϸ°û±¬·¢µÄǨáãСÌåCAAÖÐ×÷ÓûúÖÆÊ¾Òâͼ
ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÉñ¾ÄڿƺúÃÎÑÕ²©Ê¿¡¢¡¢¡¢ÀîÌú÷²©Ê¿Îª±¾ÎĵÄÅäºÏµÚÒ»×÷Õß¡£¡£ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÔ²¡ÖÐÐIJÌε¸±Ñо¿Ô±¡¢¡¢¡¢Â½ÕýÆë½ÌÊÚ£¬ngµç×ÓÓÎÏ·Ö×ÁöÖÐÐÄÁõÇ¿½ÌÊÚΪÅäºÏͨѶ×÷Õß¡£¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.nature.com/articles/s41467-023-39693-x